FEG
MD icon

Financial Enhancement Group’s Pediatrix Medical MD Stock Holding History

Financial Enhancement Group’s Portfolio MD Stock Details MD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-3,050
Closed -$203K – 66
2016
Q4 		$203K Buy
+3,050
New +$198K 0.11% 60

Other funds holding MD

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

Financial Enhancement Group's MD Position: Q1 2017 in Review

Financial Enhancement Group sold out of Pediatrix Medical (MD) in Q1 2017, closing a stake of 3,050 shares — an estimated $203K sold.

Financial Enhancement Group first reported a position in MD in Q4 2016 and held it in 1 quarter. The position peaked at $203K in Q4 2016. 359 funds tracked by Wall St. Rank hold MD as of Q1 2017.

  • Financial Enhancement Group reported no remaining Pediatrix Medical position as of Q1 2017 after selling out during the quarter.
  • Financial Enhancement Group sold 3,050 Pediatrix Medical shares in Q1 2017, an estimated $203K.
  • Financial Enhancement Group first reported a position in Pediatrix Medical in Q4 2016 and held it in 1 quarter.
  • Financial Enhancement Group's Pediatrix Medical position peaked at $203K in Q4 2016.
  • 359 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2017.

Based on Financial Enhancement Group's 13F filing for Q1 2017, filed 9 May 2017.